Innoscripta: I find insider purchases and attractive dividend yield convincing!

This ongoing year demonstrates why Innoscripta SE (i.) should be on investors' radar. For the first half of the year, a revenue growth of 43% and an increase in the adjusted EBIT margin from 56.9% to 57.7% have been reported. Although there were temporary delays due to the migration of the software platform Clusterix, the fundamental dynamics remain intact. I also find the expansion efforts exciting. Recently, over 30 new customers were reported in the Austrian funding market, and entry into the U.S. market could offer further potential. This further...